Volitionrx (VNRX) Shares Outstanding (2011 - 2025)
Volitionrx (VNRX) posted Shares Outstanding (Entity) of $100590.0 for Q4 2025, up 40.83% on a QoQ basis from $71425.0 in Q3 2025, and up 175.44% year-over-year from $36520.0 in Q4 2024.
Volitionrx (VNRX) Shares Outstanding (2011 - 2025) Analysis & Trends
Volitionrx's Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $100590.0 for Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 175.44% year-over-year to $100590.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100590.0 (up 175.44% YoY) and the FY2025 annual result came in at $100590.0, up 175.44% from the prior year.
- Shares Outstanding (Entity) was $100590.0 for Q4 2025 at Volitionrx, up from $71425.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.6 million in Q3 2024 and bottomed at $4878.0 in Q1 2025.
- A 5-year average of $2.5 million and a median of $2.7 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Peak annual rise in Shares Outstanding (Entity) reached 175.44% in 2025, while the deepest fall reached 99.88% in 2025.
- Volitionrx's Shares Outstanding (Entity) stood at $2.7 million in 2021, then advanced by 7.63% to $2.9 million in 2022, then soared by 41.51% to $4.1 million in 2023, then sank by 99.11% to $36520.0 in 2024, then soared by 175.44% to $100590.0 in 2025.
- Business Quant data shows VNRX's Shares Outstanding (Entity) at $100590.0 in Q4 2025, $71425.0 in Q3 2025, and $41414.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 100,590.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,590.00 |
| Sep 30, 2025 | 71,425.00 |
| Jun 30, 2025 | 41,414.00 |
| Mar 31, 2025 | 4,878.00 |
| Dec 31, 2024 | 36,520.00 |
| Sep 30, 2024 | 4.39 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.69 Mn |
| Mar 31, 2022 | 2.69 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 2.65 Mn |
| Mar 31, 2021 | 2.55 Mn |